0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Phenylpropanolamine-Associated Headache-Reply

JAMES F. BALE JR, MD
Am J Dis Child. 1985;139(4):331. doi:10.1001/archpedi.1985.02140060012007.
Text Size: A A A
Published online

In Reply.—The case described by Dr Higgins and colleagues further illustrates that phenylpropanolamine-related neurologic symptoms probably occur relatively frequently. Acute hypertension and headache have been the most commonly reported major complications of phenylpropanolamine use,1-3 and many other cases have likely been unrecognized. The studies of Horowitz, et al3 from Australia suggest that hypertension and associated symptoms were dose-related and that hypertension was more likely to occur when the dose of phenylpropanolamine exceeded 50 mg. However, these studies were done in healthy young adults between the ages of 21 and 28 years, and to our knowledge similar studies have not been done in younger subjects. Thus, the magnitude of the risk of phenylpropanolamine-containing anorectic preparations has not been adequately determined for children and adolescents.

These cases emphasize that physicians who treated adolescents with acute headache or other neurologic symptoms should obtain an accurate drug history regarding the use of

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();